Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM
- 10 February 2016
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 113 (9) , 2544-2549
Abstract
Significance: The systematic discovery of new gene and drug combinations that modulate complex biological phenotypes and human diseases requires scalable and multiplexed screening technologies. We leverage the programmability of the CRISPR-Cas9 system for multiplexed targeting of specific genomic loci and the versatility of the combinatorial genetics en masse (CombiGEM) technology to rapidly assemble barcoded combinatorial genetic perturbation libraries that can be tracked with high-throughput sequencing. CombiGEM-CRISPR enables simple, massively parallel screening of barcoded combinatorial gene perturbations in human cells, and the translation of these hits into effective drug combinations. This approach is broadly applicable for performing pooled combinatorial genetic perturbations to map out how the orchestrated action of genes controls complex phenotypes and to translate these findings into novel drug combinations.Keywords
This publication has 54 references indexed in Scilit:
- High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificityNature Biotechnology, 2013
- RNA-Guided Human Genome Engineering via Cas9Science, 2013
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- A programmable microfluidic cell array for combinatorial drug screeningLab on a Chip, 2012
- Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung CancerCancer Discovery, 2011
- False negative rates in Drosophila cell-based RNAi screens: a case studyBMC Genomics, 2011
- The Genetic Landscape of a CellScience, 2010
- Combinatorial patterns of histone acetylations and methylations in the human genomeNature Genetics, 2008
- The Epigenomics of CancerCell, 2007
- Epigenetic therapy of cancer: past, present and futureNature Reviews Drug Discovery, 2006